Somatic morbidity in bipolar disorders

Area of Science:

• Psychiatry and Public Health
• Epidemiology
• Somatic Medicine

Background:

• Bipolar disorder (BD) is a severe mental health condition associated with significant morbidity and mortality.
• Previous research suggests a link between BD and various somatic disorders, but large-scale, nationwide data are needed to confirm these associations across different subtypes and demographic groups.
• Understanding these comorbidities is crucial for developing effective, integrated healthcare strategies.

Purpose of the Study:

• To investigate the nationwide associations between bipolar disorder (BD) and a wide spectrum of somatic disorders in a large Swedish cohort.
• To examine whether these associations differ based on BD subtype (type 1 vs. type 2), sex, or history of compulsory psychiatric care.
• To provide robust epidemiological data to inform clinical practice and public health initiatives.

Main Methods:

• A Swedish nationwide cohort study included 61,071 individuals diagnosed with BD (inpatient/outpatient) and compared them to controls without BD.
• Data were collected from 1973 to 2020, including individuals born in 1932 or later.
• Cox regression models were used to estimate hazard ratios (HRs) for various somatic conditions, with specific analyses for BD subtypes and individuals with compulsory care history.

Main Results:

• Bipolar disorder was significantly associated with increased risks for most examined somatic conditions, notably sleep disorders (HR 3.79) and dementias (HR 4.32).
• An elevated risk for type 2 diabetes was observed, but no association with type 1 diabetes was found.
• While most risks were similar across BD subtypes, migraine and fibromyalgia showed stronger associations with type 2 BD. Compulsory care history was linked to elevated risks for several conditions.

Conclusions:

• Bipolar disorder is linked to substantially higher lifetime risks for a broad range of somatic conditions, irrespective of sex or subtype.
• The findings underscore the critical need for integrated psychiatric and somatic healthcare models.
• Improved integrated care has the potential to reduce overall morbidity and enhance health outcomes for individuals with BD.